These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6674149)

  • 1. Inhibition of alkaline ribonuclease activity by nogalamycin.
    Biswas N; Chakraborty B; Choudhury K; Neogy RK
    Indian J Exp Biol; 1983 Sep; 21(9):517-8. PubMed ID: 6674149
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of nogalamycin on tumour promotion.
    Lee MP; Chaudhuri RV
    Indian J Physiol Pharmacol; 1983; 27(2):187-8. PubMed ID: 6411614
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture.
    Bhuyan BK; Blowers CL; Crampton SL; Shugars KD
    Cancer Res; 1981 Jan; 41(1):18-24. PubMed ID: 7448758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethality of nogalamycin, nogalamycin analogs, and adriamycin to cells in different cell cycle phases.
    Bhuyan BK; Blowers CL; Shugars KD
    Cancer Res; 1980 Oct; 40(10):3437-42. PubMed ID: 7438031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogalamycin inhibits ribonucleic acid synthesis in growing and developing cells of the slime mold Dictyostelium discoideum.
    Ennis HL
    Antimicrob Agents Chemother; 1981 Apr; 19(4):657-65. PubMed ID: 7247388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative characteristics of ribonuclease isolated from the lliver and pancreas of burned and intact rats].
    Borisova TA; Raben NA
    Biull Eksp Biol Med; 1976 Mar; 81(3):305-7. PubMed ID: 953275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA base sequence preference for adriamycin and nogalamycin binding.
    Choudhury K; Chakraborty R; Dhar TC; Neogy RK
    Indian J Biochem Biophys; 1985 Jun; 22(3):166-72. PubMed ID: 4077090
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of x-irradiation on the balance between the alkaline ribonuclease and the alkaline ribonuclease inhibitor of mammalian tissues.
    Kraft N; Shortman K; Jamieson D
    Radiat Res; 1969 Sep; 39(3):655-68. PubMed ID: 5806700
    [No Abstract]   [Full Text] [Related]  

  • 10. The phylogeny of the ribonuclease-ribonuclease inhibitor system: its distribution in tissues and its response during leukaemogenesis and aging.
    Kraft N; Shortman K
    Aust J Biol Sci; 1970 Feb; 23(1):175-84. PubMed ID: 4920211
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular models for the interaction of the anti-tumour drug nogalamycin with DNA.
    Collier DA; Neidle S; Brown JR
    Biochem Pharmacol; 1984 Sep; 33(18):2877-80. PubMed ID: 6477647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure--activity relationships of nogalamycin analogues.
    Wiley PF; Elrod DW; Houser DJ; Richard FA
    J Med Chem; 1982 May; 25(5):560-7. PubMed ID: 7086843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of daunomycin on alkaline ribonuclease activities of normal and neoplastic tissues.
    Biswas N; Chakraborty BK; Chowdhury K; Neogy RK
    Indian J Cancer; 1974 Sep; 11(3):301-4. PubMed ID: 4442920
    [No Abstract]   [Full Text] [Related]  

  • 14. Template specificity of DNA binding by nogalamycin and its analogs utilizing competitive fluorescence polarization.
    Richardson CL; Grant AD; Schpok SL; Krueger WC; Li LH
    Cancer Res; 1981 Jun; 41(6):2235-40. PubMed ID: 7237423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of nogalamycin & ethidium bromide with chromatin & DNA - histone (f1) complex.
    Chatterji H; Deb JK; Neogy RK
    Indian J Biochem Biophys; 1980 Dec; 17(6):421-3. PubMed ID: 7251027
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of nogalamycin to model tetranucleotides.
    Trinquier G; Chen KX; Gresh N
    Biopolymers; 1988 Sep; 27(9):1491-517. PubMed ID: 3219408
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of nogalamycin with chromatin.
    Ganguli R; Chowdhury K; Chakraborty B; Neogy RK
    Chem Biol Interact; 1983 Sep; 46(3):347-52. PubMed ID: 6640781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
    Dodion P; Sanders C; Rombaut W; Rozencweig M; Kitt MM; Kenis Y; Klastersky J
    Eur J Cancer Clin Oncol; 1986 Mar; 22(3):245-9. PubMed ID: 2940092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of nogalamycin-DNA complex as chemotherapeutic agent.
    Chakraborty B; Nandi J; Neogy RK
    Indian J Exp Biol; 1979 Jun; 17(6):595-7. PubMed ID: 500141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Specificity of tissular inhibitions of free ribonuclease activity].
    Scheggia ER; Trémolières J
    C R Seances Soc Biol Fil; 1967; 161(7):1521-6. PubMed ID: 4231622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.